Ultralife Corp insider trading
Every open-market purchase and sale by Ultralife Corp's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Ultralife Corp’s insiders pay?
From May 19, 2010 to May 26, 2026, 10 insiders reported 87 open-market purchases and 3 sales not made under a pre-set plan in Ultralife Corp. Twelve months after each purchase was reported, the shares were −15.4% against the S&P 500 on average (median −21.7%), over 45 purchases with a full year of prices; 20% beat the index. After sales, the shares moved −44.7% against the index over 12 months (a negative figure means selling was the right call). Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on March 16, 2011 into $17,569 by November 2, 2026, +3.7% a year. It held shares 74% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $45,180 (+10.2% a year), and held throughout $78,982 (+14.2%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Whitmore Bradford T | Director | 36 | −18.6% (20) | 15% | 1 | — | May 26, 2026 |
| Robert W. Shaw | Director | 12 | −13.1% (10) | 20% | 0 | — | May 14, 2025 |
| Popielec Michael D | Director, President and CEO | 10 | −38.4% (1) | 0% | 0 | — | November 4, 2016 |
| Saeli Thomas Louis | Director | 9 | +14.8% (5) | 60% | 0 | — | May 14, 2025 |
| Manna Michael Edward | President and CEO | 7 | −28.4% (2) | 0% | 0 | — | May 18, 2026 |
| Fain Philip A | CFO and Treasurer | 5 | −11.0% (3) | 33% | 0 | — | December 16, 2021 |
| Barron Patricia C | Director | 3 | −14.2% (1) | 0% | 0 | — | May 10, 2011 |
| Goddard Janie | Director | 3 | −40.4% (3) | 0% | 0 | — | June 13, 2025 |
| Anderson Steven Mark | Director | 1 | — | — | 1 | — | May 10, 2016 |
| Croce James A. | Director | 1 | — | — | 1 | −44.7% (1) | February 24, 2012 |
When several insiders traded Ultralife Corp
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Ultralife Corp in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 9 buying crowds with six months of prices, it averaged −2.5% against the index. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| March 31, 2026 | 2 buying | −19.0% | −18.8% | not yet |
| May 30, 2025 | 4 buying | −5.6% | −31.3% | −23.8% |
| November 29, 2024 | 2 buying | −18.6% | −2.0% | −41.2% |
| December 31, 2021 | 2 buying | −5.3% | −6.2% | −19.4% |
| March 31, 2020 | 2 buying | +14.6% | −11.2% | +3.0% |
| December 31, 2018 | 2 buying | +40.2% | +5.0% | −21.7% |
| December 29, 2017 | 2 buying | +56.1% | +41.5% | +13.6% |
| June 30, 2017 | 2 buying | −10.7% | −20.5% | +16.7% |
| November 30, 2016 | 2 buying | +7.0% | +20.7% | +7.0% |